Professional Medical Billing is a medical billing firm located in Saginaw, Michigan. Professional Medical Billing has provided medical billing services throughout the state of Michigan since 1987.
more...US researchers studying yeast cells found that ageing cells able to retain a group of proteins that ferry compounds across cellular membranes and get rid of toxic waste have a longer lifespan in that they can produce more copies of themselves compared with cells that lose their waste disposal proteins; they also hope their finding may help us better understand stem cells and cancer cells…
Adult stem cell leader Neostem, Inc. (NYSE Amex: NBS) has been awarded a $700,000 military grant from the U.S. Army’s Medical Research and Materiel Command to study adult stem cell applications in the healing of trauma wounds. The award opens new opportunities for the company’s patented VSEL technology. Shares of Neostem rose more than 5 percent on the news. In a statement released to the press, Neostem founder and Chairwoman Dr…
The transplantation of stem cells from a healthy donor (allogeneic) offers the chance of cure for patients with an aggressive form of chronic lymphocytic leukemia (CLL), irrespective of genetic prognostic factors and the prior course of the disease. The German CLL Study Group proved this in a multicentric clinical phase II study led by Professor Dr. Peter Dreger, senior consultant and head of the division of stem cell transplantation at the Department of Internal Medicine V at Heidelberg University Hospital.
Source: HealthDay – 
Related MedlinePlus Pages: Childbirth, Stem Cells
New research from Japan suggests that dental pulp from extracted teeth may be an easy source of Induced Pluripotent Stem (IPS) cells, which like embryonic stem cells, have the potential to form several different cell types, but without the controversial ethical problems. These were the findings of a study led by K. Tezuka from the Gifu University Graduate School of Medicine in Japan, that was published online in the journal Journal of Dental Research on 16 June…
Cellonis, a Beijing and HK-based biotech company, with its new personalized diabetes treatment concept has demonstrated an amazing improvement in their treated patients’ conditions. The ongoing clinical study shows the treatment’s best case could reconstruct a patient’s natural insulin production and even reverse later complications like kidney failure. Treated patients may have the chance to return to the normal activities non-diabetes sufferers take for granted.
A regenerative treatment that uses stem cells taken from the patient’s own eyes is helping some blind patients see again.
The new cancer medication sorafenib looks promising. Sorafenib is used for advanced liver and kidney cancer and also appears to be effective against cancer stem cells in pancreatic cancer. The team led by Professor Dr. Ingrid Herr, Head of the Department of Molecular Oncosurgery, a group of the Department of Surgery at Heidelberg University Hospital, (Managing Director: Professor Dr. Markus W. Büchler) in cooperation with the German Cancer Research Center, tested the new substance in mice and pancreatic cancer cells…
Cyntellect, Inc., a privately-held life sciences company commercializing products to advance the study of cell biology, stem cell research, biopharmaceutical production, and drug discovery, announced today the commercial availability of its Stem Cell Colony Purification Application powered by the LEAP™ Cell Processing Workstation.
Stem cell research holds promise for improving the quality of human life ― especially embryonic stem cells, which can potentially develop into any tissue in the human body. However, basic scientific problems still remain unresolved — but Tel Aviv University researchers are leading the way to inventive solutions.
BioTime, Inc. announced today that on June 1, 2010 the Company will be offering for sale five new human stem cell lines for research use only. These cell lines were developed using BioTime’s ACTCellerate™ technology. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem cells and fully developed cells.
Being able to grow and program human motor neurones in the lab has been the dream motor neurone disease scientists for several years. The Motor Neurone Disease (MND) Association is funding its first ever stem cell research program with the aim of finding the secrets of this neurological condition. Spelling – Motor Neurone Disease or Motor Neuron Disease are both possible spellings…
Geron Corporation (Nasdaq:GERN) today reported positive preclinical study data showing that GRNCM1, Geron’s cardiomyocyte product derived from human embryonic stem cells (hESCs), does not cause cardiac arrhythmias after transplantation into a model of chronic heart damage designed to test this potential safety concern. GRNCM1 is being developed for the treatment of heart failure. The data were presented today at the 31st Annual Scientific Sessions of the Heart Rhythm Society in Denver, CO by Geron collaborator Dr…
“[L]ittle-noticed provisions” in the health reform law (PL 111-148) have “quietly reignited” a debate over balancing patients’ rights to receive care with some health workers’ moral and religious objections to certain services and procedures, the Washington Post reports. Supporters of increased “conscience” protections for health workers argue that the new law “leaves vulnerable” those who oppose abortion, emergency contraception, stem cell research and some end-of-life care…
New evidence in embryonic stem cells shows that mammalian genes may all have a layer of control that acts essentially like the pause button on your DVR. The researchers say the results show that the pausing phenomenon, previously thought to be a peculiarity of particular genes, is actually a much more general feature of the genome. The findings are reported in the April 30th issue of the journal Cell, a Cell Press publication…
The volcanic ash plume that is currently over and still blowing towards the UK from the eruptions in Iceland’s Eyjafjallajokull volcano poses little or no threat to public health, says the UK’s Health Protection Agency (HPA), however, reports are coming in that the resulting transport disruption could create considerable medical problems, for example to patients in a vulnerable state waiting for transplant stem cells from overseas. As for the ash itself, the HPA said most people will be largely unaffected…
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced the launch of the newest adult stem cell collection center in its network to open in Austin, TX on April 15, 2010.
In a letter to the editor of the Washington Post about a recent article on embryonic stem cell research, NIH Director Francis Collins writes that he is “concerned that readers might come away … confused about what is happening” at the agency. He adds that “stem cell research is progressing rapidly, thanks to President Obama’s new policy” (Collins, Washington Post, 3/20). The Post article reported that although the Obama administration has lifted many of President George W…
Hemangiomas — strawberry-like birthmarks that commonly develop in early infancy – are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing. Since the 1960s, problematic hemangiomas have been treated with corticosteroids such as dexamethasone or prednisone.
Although restrictions on federal funding for human embryonic stem cell research have been lifted under the Obama administration, some researchers are finding the new ethical requirements burdensome, the Washington Post reports. Under the George W. Bush administration, only 21 stem-cell “lines” were permitted to receive federal research funding. President Obama relaxed the restrictions but allowed the National Institutes of Health to issue ethics guidelines…
Recent Comments